RAP 0.00% 20.5¢ resapp health limited

Ann: Further Positive Results From Adult Clinical Study-RAP.AX, page-2

  1. 1,175 Posts.
    lightbulb Created with Sketch. 14
    - Achieved high levels of accuracy (91%-100%) for distinguishing adult patients
    with URTI, COPD, asthma or pneumonia from subjects with no discernible
    respiratory disease
    - Demonstrated differential diagnosis of asthma versus COPD, pneumonia
    versus asthma and pneumonia versus COPD at 88%-94% accuracy
    - Correctly detected lower respiratory tract disease in 84% of adult patients
    initially diagnosed as clear by experienced clinicians using stethoscopes
    - Finalised clinical protocol and confirmed three leading US hospitals for US
    paediatric study, SMARTCOUGH-C
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.